Urologic cancer

Clinically supported, precision evaluations

For patients impacted by urologic malignancies, including renal, bladder, and prostate cancer, identifying whether the illness is genetic in origin is key to defining and classifying the tumor subtype. Because certain genetic variants have diagnostic, prognostic, and therapeutic associations, understanding the cancer’s genetic traits can help physicians better care for and direct treatment. Additionally, identifying pathogenic variants can support familial screening and genetic counseling for a variety of hereditary cancer syndromes.

Urologic cancer test menu

Urologic cancer

Our MayoComplete next-generation sequencing urology panels were carefully curated by a collaborative team of clinical experts, geneticists, and genetic counselors to include only clinically relevant genes. Focused, actionable, and cost-effective, our panels provide individualized insights that clarify the disease process and set patients on the right treatment path.

Key testing

Additional testing


Hereditary Urologic cancer

Key testing


Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.